Credit: Photo by Cedars-Sinai.
Karen L. Reckamp, MD, director of Medical Oncology at Cedars-Sinai Cancer, presents new data suggesting an immunotherapy drug combination can extend the lives of those diagnosed with advanced non-small cell lung cancer.